In the post-treatment tumor specimen of Patient 1, there was emergence of BRAF copy number amplification, which is a known mechanism of resistance to type 1 RAF inhibition in cancer cells harboring the BRAF p.V600E mutation34. The gene discussed is BRAF; the disease is cancer.